XNAS
BSLK
Market cap4mUSD
Jul 14, Last price
2.32USD
1D
0.87%
1Q
827.63%
IPO
-68.18%
Name
Golden Arrow Merger Corp
Chart & Performance
P/E
—
P/S
3.48
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
1m
Net income
-65m
L+4,355.74%
CFO
-16m
L+828.79%
Profile
Golden Arrow Merger Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare-related infrastructure industries in the United States and other developed countries. Golden Arrow Merger Corp. was incorporated in 2020 and is based in New York, New York.
IPO date
Mar 19, 2021
Employees
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY |
|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | |
| Income | ||||
Revenues | 1,373 | |||
Cost of revenue | 42,981 | |||
Unusual Expense (Income) | ||||
NOPBT | (41,608) | |||
NOPBT Margin | ||||
Operating Taxes | 653 | 760 | ||
Tax Rate | ||||
NOPAT | (41,608) | (653) | (760) | |
Net income | (65,393) 4,355.74% | (1,468) -114.90% | 9,847 86.88% | |
Dividends | ||||
Dividend yield | ||||
Proceeds from repurchase of equity | 360 | (287,072) | ||
BB yield | ||||
| Debt | ||||
Debt current | 2,063 | 89 | ||
Long-term debt | 13,186 | |||
Deferred revenue | ||||
Other long-term liabilities | 817 | 12,104 | 10,208 | |
Net debt | 9,674 | (4,461) | (290,906) | |
| Cash flow | ||||
Cash from operating activities | (16,147) | (1,738) | (1,647) | |
CAPEX | (23) | |||
Cash from investing activities | (23) | 287,605 | 871 | |
Cash from financing activities | 18,810 | (285,909) | 759 | |
FCF | (45,653) | 1,983 | (652) | |
| Balance | ||||
Cash | 3,512 | 306 | 349 | |
Long term investments | 6,218 | 290,646 | ||
Excess cash | 3,443 | 6,524 | 290,995 | |
Stockholders' equity | (461,778) | (11,949) | 280,272 | |
Invested Capital | 467,171 | 14,849 | 10,049 | |
ROIC | ||||
ROCE | ||||
| EV | ||||
Common stock shares outstanding | 14,699 | 35,938 | ||
Price | 0.48 | |||
Market cap | ||||
EV | ||||
EBITDA | (41,606) | |||
EV/EBITDA | ||||
Interest | 1,504 | 11,950 | ||
Interest/NOPBT | ||||